PorTal Access, Inc., an innovative medical device company advancing vascular access technologies, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance for the ...
Medical Device Network on MSN
Portal Access secures FDA clearance for vascular access ports
The FLEXI-PORT family of vascular access devices are designed to offer as a flexible and versatile to improve the patient and ...
Heterozygous Germline ATM Mutations Do Not Contribute to Radiation-Associated Malignancies After Hodgkin's Disease PURPOSE: To examine the safety, efficacy, costs, and impact on quality of life of ...
We write as clinicians and cancer survivors who underwent prolonged chemotherapy for oesophageal cancer. Our experiences highlight how access to implantable venous access devices (chemotherapy ports) ...
VANCOUVER, BC, CANADA, October 31, 2023 /EINPresswire.com/ -- iData Research, a leading global market research firm specializing in medical devices, dental and ...
Sophysa offers a complete range of CE-marked implantable brain shunts for the treatment of hydrocephalus as well as implantable access ports for chemotherapy and morphine therapy. These products are ...
A chemotherapy (chemo) port is a small device implanted just under the skin in the chest. It’s usually placed on the right side, near a major vein called the vena cava, and is used to administer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results